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Case presentation
A 71-year-old male with hyperlipidemia, hypertension, Paroxysmal Atrial Fibrillation (PAF), Ischemic Heart Disease (IHD), Ischemic Cerebrovascular Accident (CVA), with permanent ICD for primary prevention was admitted to the neurological department with a paresthesia and numbness of the face and extremities. On neurological examination extreme proximal muscle weakness with poor sensation of palms and soles, depressed reflexes and unsteady walking. The cranial CT showed old small infarcts. His background treatment included: P.O. Aspirin 100 mg q.d., P.O. Atorvastatin 40 mg q.d., P.O. Enaladex 5 mg q.d., P.O. Sotalol 40 mg b.i.d. He was started on treatment with plasmapheresis and 3 days later IVIG treatment was added. During admission bacteremia with Klebsiella Pneumonia on blood culture and treatment with Tazocin was started.
Three days later the patient began to have recurrent episodes of sustained VT (Figure 1) . The ICD did not sense the events because the threshold rate for VT detection was higher than the actual rate of VT in this patient. The patient was hemodynamically stable during each episode of VT. Treatment was started with Amiodarone, beta-blockers and the patient received DCA cardio version on two occasions. 19
Discussion
The Guillain-Barre syndrome, which is characterized by acute areflexic paralysis with albuminocytologic dissociation (i.e., high levels of protein in the cerebrospinal fluid and normal cell counts), was described in 1916 [1] . Since poliomyelitis has been eliminated, the Guillain-Barre syndrome is currently the most frequent cause of acute flaccid paralysis worldwide and constitutes one of the serious emergencies in neurology [2] .
The presentation of GBS may be acute or sub-acute in presentation [2] . It affects the peripheral nerves and is characterized by symmetrical progressive ascending weakness with areflexia and variable sensory complaints [3, 4] . The GBS is presumed to be caused by an aberrant auto immune response against peripheral nerves by cross-reacting antibodies [5, 6] . The incidence of the GBS is estimated at 1 to 2 per 100,000 per year with a preponderance in women over 50 years of age [7, 8] . GBS is often preceded by an infection that is believed to evoke an immune response [9] . The classification is based on nerveconduction studies and there is a notable difference in the geographic distribution of subtypes of the syndrome [10, 11] The classic pathological findings in acute inflammatory demyelinating polyneuropathy are inflammatory infiltrates (consisting mainly of T cells and macrophages) and areas of segmental demyelination, often associated with signs of secondary axonal degeneration, which can be detected in the spinal roots, as well as in the large and small motor and sensory nerves ( Figure 2 ) [12] . The immune response leads to a crossreaction with peripheral nerve components because of shared epitopes resulting in acute polyneuropathy [13] . This is further supported by the identification of various antiganglioside antibodies noted in necropsy and animal models that cross-react with the ganglioside surface molecules of peripheral nerves [9, 12] . This phenomenon may also explain the potential involvement of the heart, which possesses lactosecontaining gangliosides. Different degrees of affliction of the autonomic nervous system can be seen in up to 70% of patients with the GBS [13] . Current data suggest sympathetic over activity rather than parasympathetic hypo activity in such patients [14] . It is postulated that a failure of catecholamine uptake in the "irritated" peripheral nerves may be responsible for this activity [15] . In addition, the denervated organs have been noted to be increasingly sensitive to catecholamines, resulting in denervation hypersensitivity [16] .
Cardiovascular disturbances are believed to be secondary to a combination of this entity in addition to impairment of the carotid sinus reflex [17] . Cardiovascular abnormalities in the GBS have been attributed to autonomic neuropathy in the efferent fibers of the vagus nerves, and are seen in about of 70% of affected patients [18] . However, autopsy findings have not confirmed these changes [19, 20] . Other cardiac complications have also been described in the patients with Guillian-Barre syndrome, mainly: heart rate variability, BP variability, cardiomyopathy, and electrocardiographic changes ( Table  1 ) [12, 21, 22] .
Rhythm abnormalities

Brady arrhythmias
Sustained sinus tachycardia Atrial and ventricular arrhythmias Blood pressure variability Hypotension Hypertension
Myocardial involvement
Myocarditis Neurogenic stunned myocardium Heart failure Acute coronary syndromes
ST elevation myocardial infarction
Electrocardiographic changes
Giant T waves Prolonged QT intervals ST-T changes U waves Atrioventricular block Bradycardia and tachycardia Table 1 : Common cardiovascular complications of the Guillain-Barré syndrome.
Sustained sinus tachycardia is the most common abnormality. This was believed to be due to sympathetic hyperactivity [14] . Due to its transient nature, the treatment is usually supportive [23] . Other tachyarrhythmias, including atrial and ventricular arrhythmias, may also occur [22] . There have been two anecdotal reports of ventricular tachycardia and fibrillation after administration of muscle relaxants for tracheal intubation or tracheostomy [24] . There have been no other reports in the literature of spontaneous VT in patients with GBS. We know that there is a wide spectrum of main etiologies of VT like cardiomyopathies (with coronary disease), long QT and Brugada syndrome as well as adverse effects of different medications and electrolyte imbalances [25] . Our patient had known CAD with severe left ventricular dysfunction and this underlying condition may have responsible for the VT occurring during this acute illness.
Bradyarrhythmias including atrioventricular block and asystole, have been reported in 7% to 34% of patients and may occur in up to 50% of patients with GBS, and are potentially serious events necessitating the administration of atropine or pacemaker placement [14, 26] . Vagal over activity caused by afferent baroreceptors reflex failure is believed to be a pathogenesis for bradycardia. Aggressive correction of associated factors such as hypoxia, medication side effects, and metabolic abnormalities may help in prevention [27] . Where severe bradycardia has been described no published consensus has been reached on whether to implant a temporary or permanent pacemaker-as recovery of these patients and infective complications are hard to predict [28] .
Blood Pressure (BP) variability can be attributed to disturbances in the baroreceptor reflex pathway as well as to changes in the catecholamine levels. The dysregulation of the parasympathetic and sympathetic systems is responsible for alterations in venomotor tone and peripheral vascular resistance, most often causing transient, but in some cases, persistent hypotension. Fluctuations in BP are often considered as pathognomonic for the GBS and are likely to occur in critical illnesses or neuropathy [29] .
Although these episodes of BP deviation were most often related to mechanical ventilation, analgesia, and sedation they may also occur without sedation [14] . There are no specific recommendations for target mean arterial pressure and the treatment is mainly symptomatic either with fluids and inotropes for hypotension and with IV antihypertensive therapy and/or vasodepressors for hypertension. The possible mechanisms are denervation hypersensitivity, but other contributing conditions, such as pulmonary thromboembolism, hypoxemia, sepsis, gastrointestinal bleeding, and metabolic abnormalities, need to be considered [13, 30] .
Myocardial involvement ranges from asymptomatic myocarditis to neurogenic stunned myocardium and heart failure. It can arise from the activation of the sympathetic nervous system, caused by catecholamine-associated myocardial injury but infectious, chemicals and hypersensitivity medications can also account for this damage [31, 32] . It is possible that the extent of myocardial involvement has been underestimated as routine 2-dimensional echocardiography is not performed in this critically ill cohort of patients (including on mechanical ventilation) [33] .
There are anecdotal reports of acute coronary syndromes, including ST-segment elevation myocardial infarction occurring during therapy for GBS with intravenous immunoglobulin [34] . In another report intracoronary Doppler flow measurements revealed an elevated baseline coronary flow velocity with a decreased coronary flow reserve, supposedly secondary to a catecholamine surge [33] .
A wide spectrum of electrocardiographic changes have been demonstrated, including giant T waves, prolonged QT intervals, ST-T changes, U waves, and atrioventricular block, in addition to bradycardia and tachycardia as previously described [35] . These changes are also believed to be secondary to associated myocardial involvement. Along with 2-dimensional echocardiographic studies, other modalities to demonstrate cardiac involvement such as iodine-123 meta-iodobenzylguanidine myocardial scintigraphy and carbon-11 hydroxyephedrine positron emission tomography can also be used to study sympathetic innervation of myocardium [36] .
Conclusions
GBS is the most common cause of acute flaccid paralysis in young adults and the elderly and an important cause of admission to intensive care units. Critically ill patients with paralysis and need for mechanical ventilation often have cardiac involvement. This ranges from variations in blood pressure to involvement of the myocardium and potentially fatal arrhythmias. A thorough review of the literature shows rare reports of a wide spectrum of cardiac abnormalities, with no reported spontaneous VT. We suggest that careful cardiac assessment of patients with GBS be performed including continuous ECG monitoring as well as measurement of cardiac enzymes and 2-D Echocardiography.
